ISDA

Entry Detail

PDB ID:

4Y2H

Keywords:

TRANSFERASE

Title:

Crystal structure of human protein arginine methyltransferase PRMT6 bound to SAH and an aryl pyrazole inhibitor

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2015-02-09

Release Date:

2015-04-22

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.37 Å

R-Value Free:

0.23

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

P 43

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Protein arginine N-methyltransferase 6
Chain IDs:A, B
Chain Length:352
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:Q96LA8 Pfam ID:PF13649, PF22528 EC:2.1.1.319

Ligand Molecules

49K

GOL

SAH

Primary Citation

Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound.

Mitchell, L.H, Drew, A.E, Ribich, S.A, Rioux, N, Swinger, K.K, Jacques, S.L, Lingaraj, T, Boriack-Sjodin, P.A, Waters, N.J, Wigle, T.J, Moradei, O, Jin, L, Riera, T, Porter-Scott, M, Moyer, M.P, Smith, J.J, Chesworth, R, Copeland, R.A.Show

Acs Med.Chem.Lett. 6 655 659 (2015)

PMID: 26101569 DOI: 10.1021/acsmedchemlett.5b00071

Abstact

A novel aryl pyrazole series of arginine methyltransferase inhibitors has been identified. Synthesis of analogues within this series yielded the first potent, selective, small molecule PRMT6 inhibitor tool compound, EPZ020411. PRMT6 overexpression has been reported in several cancer types suggesting that inhibition of PRMT6 activity may have therapeutic utility. Identification of EPZ020411 provides the field with the first small molecule tool compound for target validation studies. EPZ020411 shows good bioavailability following subcutaneous dosing in rats making it a suitable tool for in vivo studies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures